StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3037% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Workforce by geography

Workforce by geography — Canada employees (standalone FY2015–FY2016, headcount)

Vertex Pharmaceuticals Workforce by geography: 75.00 employees in FY2016, unchanged from a year earlier. No newer figure appears in the documents we track.

Latest, FY2016
75.00
Period ended Dec 31, 2016
Change on a year earlier
0.0%
75.00 in FY2015
History
2 years
Since FY2015
Sources
2
Documents cited below

Where the FY2016 figure comes from

“Of these employees, approximately 1,725 were based in the United States, approximately 350 were based in Europe and approximately 75 were based in Canada.”

Source: Form 10-K (a201610k-main.htm, filed 2017-02-23) ↗

Reported in Form 10-K Item 1 (Business — Employees, FY2015–FY2016).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedWorkforce by geography — Canada employees (standalone FY2015–FY2016, headcount)Year on yearSource
FY2016Dec 31, 201675.000.0%Form 10-K (a201610k-main.htm, filed 2017-02-23) ↗
FY2015Dec 31, 201575.00–Form 10-K (a201510k-main.htm, filed 2016-02-16) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Workforce by geography, annual FY2015–FY2016 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/emp-canada

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.